Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Regeneron
Company Monitoring Page for Regeneron
latest headlines for company on cafepharma
5 Big Drugmakers With Important Catalysts in May
Motley Fool
Sun, 04/30/17 - 01:00 pm
Tags:
FDA
,
Merck
,
Keytruda
,
Isentress
,
Novartis
,
PKC412
,
Novo Nordisk
,
nonacog beta pegol
,
Sanofi
,
Regeneron
,
Kevzara
Will Regeneron’s Revenue Surpass Analysts’ Estimates in 1Q17?
Market Realist
Wed, 04/26/17 - 09:40 pm
Tags:
Regeneron
,
earnings
Regeneron’s CEO, CSO saw their compensation slashed in ’16 — but it’s still a jaw-dropping sum
Endpoints
Tue, 04/25/17 - 11:50 pm
Tags:
Regeneron
,
Pharma CEOs
,
executive pay
,
Leonard Schleifer
Sanofi and Regeneron Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent® (alirocumab) Injection
Yahoo
Tue, 04/25/17 - 11:04 am
Tags:
Sanofi
,
Regeneron
,
FDA
,
Praluent
EMA panel recommends nod for Sanofi, Regeneron's arthritis drug
Yahoo/Reuters
Sat, 04/22/17 - 01:14 pm
Tags:
Europe
,
EMA
,
Sanofi
,
Regeneron
,
rheumatoid arthritis
,
Kevzara
,
Sarilumab
Lilly and Incyte's Loss Is AbbVie and Regeneron's Gain
Motley Fool
Mon, 04/17/17 - 12:07 pm
Tags:
Eli Lilly
,
Inctye
,
AbbVie
,
Regeneron
,
rheumatoid arthritis
,
FDA
,
baricitinib
,
Humira
When do pharmas disclose launch prices up front? When they’re pricing at a discount
Fierce Pharma
Fri, 04/14/17 - 10:03 am
Tags:
drug discounts
,
drug pricing
,
Roche
,
Neurocrine
,
Sanofi
,
Regeneron
,
Tesaro
,
Novartis
3 Big Biotech Stocks With Big-Time Catalysts
Motley Fool
Sun, 04/9/17 - 12:36 pm
Tags:
Regeneron
,
Praluent
,
Amgen
,
biosimilars
,
Amjevita
,
Humira
,
ABP-215
,
Avastin
,
ABP-980
,
Herceptin
,
Celgene
,
ozanimod
The stellar antibody shop at Regeneron wins a ‘breakthrough’ tag for its next big PhIII drug
Endpoints
Fri, 04/7/17 - 09:48 am
Tags:
Regeneron
,
breakthrough therapies
,
evinacumab
,
LDL cholesterol
How a $37,000-a-year medicine sets a good model for drug pricing
Stat
Tue, 04/4/17 - 12:17 am
Tags:
drug pricing
,
psoriasis
,
Dupixent
,
Regeneron
Lilly, Pfizer, et al. back Sanofi and Regeneron in PCSK9 patent appeal. AbbVie doesn't
Fierce Pharma
Tue, 04/4/17 - 12:13 am
Tags:
Eli Lilly
,
Pfizer
,
Sanofi
,
AbbVie
,
Regeneron
,
patents
,
PCSK9 inhibitors
,
Repatha
Sarepta chief hands over CMO role to former Regeneron exec
Bizjournals.com
Tue, 04/4/17 - 12:09 am
Tags:
Sarepta Therapeutics
,
Regeneron
,
CMOs
Regeneron's Game-Changing New Eczema Drug Could Be a Blockbuster
Motley Fool
Thu, 03/30/17 - 09:39 am
Tags:
Regeneron
,
eczema
,
Sanofi
,
Dupixent
Can a $37,000 price be right? For Dupixent, analysts (and one payer) say yes
Fierce Pharma
Wed, 03/29/17 - 11:58 am
Tags:
drug pricing
,
Dupixent
,
Sanofi
,
Regeneron
,
eczema
As blockbuster drugs fizzle, biotech looks warily to the next big thing
Stat
Wed, 03/29/17 - 11:52 am
Tags:
biotech
,
Dupixent
,
Sanofi
,
Regeneron
FDA approves Regeneron, Sanofi $37,000 per year eczema drug
Yahoo/Reuters
Tue, 03/28/17 - 12:28 pm
Tags:
FDA
,
Dupixent
,
Sanofi
,
Regeneron
,
eczema
GSK and Regeneron to mine gene data from 500,000 Britons
Yahoo/Reuters
Wed, 03/22/17 - 10:33 pm
Tags:
GSK
,
Regeneron
,
data mining
,
UK
,
DNA
Sanofi, Regeneron Sue Amgen to Avoid Dupixent Patent Claims
Investopedia
Wed, 03/22/17 - 09:58 am
Tags:
Sanofi
,
Regeneron
,
Dupixent
,
Amgen
,
patents
,
eczema
Sanofi, Regeneron say latest Dupixent eczema drug tests positive
Yahoo/Reuters
Sat, 03/4/17 - 01:54 pm
Tags:
Sanofi
,
Regeneron
,
Dupixent
,
eczema
,
clinical trials
Sanofi confident in case to overturn Praluent ban
BioPharma Dive
Sat, 02/11/17 - 12:47 pm
Tags:
Sanofi
,
Praluent
,
Regeneron
,
Amgen
,
Repatha
Pages
« first
‹ previous
…
22
23
24
25
26
27
28
29
30
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.